Statistical Thinking For Non-statisticians In Drug Regulation - Richard Kay

Statistical Thinking For Non-statisticians In Drug Regulation Statistical Methods In The Pharmaceutical Industry Are Accepted As A Key Element In The Design And Analysis Of Clinical Studies. Increasingly, The Medical And Scientific Community Are Aligning With The Regulatory Authorities And Recognizing That Correct Statistical Methodology Is Essential As The Basis For Valid Conclusions. In Order For Those Correct And Robust Methods To Be Successfully Employed There Needs To Be Effective Communication Across Disciplines At All Stages Of The Planning, Conducting, Analyzing And Reporting Of Clinical Studies Associated With The Development And Evaluation Of Drugs And Devices.